|
Delayed
Bombay S.E.
11:02:29 07/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 35.10 INR | +9.69% |
|
+9.69% | +46.25% |
| 05-30 | Novateor Research Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 04-30 | Novateor Research Laboratories Launches New Toothpaste | MT |
Company Valuation: Novateor Research Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 40.56 | 30.26 | 41.09 | 89.43 | 205.4 | 173.5 |
| Change | - | -25.39% | 35.78% | 117.65% | 129.62% | -15.51% |
| Enterprise Value (EV) 1 | 35.04 | 26.11 | 38.7 | 95.78 | 212 | 177.2 |
| Change | - | -25.47% | 48.22% | 147.47% | 121.35% | -16.4% |
| P/E | -420x | 313x | -18.1x | 231x | 850x | 256x |
| PBR | 0.47x | 0.35x | 0.52x | 1.13x | 2.34x | 1.65x |
| PEG | - | -2x | 0x | -2x | -22.7x | 1x |
| Capitalization / Revenue | 10.3x | 16.1x | 5.54x | 7.1x | 17x | 6.25x |
| EV / Revenue | 8.88x | 13.9x | 5.22x | 7.6x | 17.6x | 6.38x |
| EV / EBITDA | 26.8x | 23.8x | 13x | 62.8x | -64.3x | -136x |
| EV / EBIT | 100x | 190x | 18.2x | 144x | -51.6x | -60.8x |
| EV / FCF | -0.91x | -8.41x | -6.04x | -17.3x | -12.3x | -10.4x |
| FCF Yield | -110% | -11.9% | -16.5% | -5.78% | -8.16% | -9.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.02 | 0.02 | -0.47 | 0.08 | 0.05 | 0.14 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 3.947 | 1.878 | 7.419 | 12.6 | 12.07 | 27.77 |
| EBITDA 1 | 1.307 | 1.098 | 2.988 | 1.524 | -3.296 | -1.305 |
| EBIT 1 | 0.3497 | 0.1375 | 2.122 | 0.6664 | -4.108 | -2.914 |
| Net income 1 | -0.0789 | 0.118 | -2.284 | 0.3665 | 0.2927 | 0.818 |
| Net Debt 1 | -5.523 | -4.149 | -2.386 | 6.351 | 6.658 | 3.735 |
| Reference price 2 | 8.39 | 6.26 | 8.50 | 18.50 | 42.48 | 35.89 |
| Nbr of stocks (in thousands) | 4,834 | 4,834 | 4,834 | 4,834 | 4,834 | 4,834 |
| Announcement Date | 04/09/20 | 07/09/21 | 07/09/22 | 08/09/23 | 05/09/24 | 08/09/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.24M | |
| 21.39x | 4.08x | 14.95x | 3.02% | 338B | |
| 18.48x | 2.74x | 12.07x | 3.49% | 137B | |
| 24.04x | 3.61x | 15.15x | 2.4% | 70.48B | |
| 41.15x | 6.61x | 28.67x | 2.27% | 49.07B | |
| 34.3x | 2.69x | 14.91x | 1.57% | 36.79B | |
| 19.34x | 2.72x | 11.34x | 4.59% | 35.32B | |
| 22.18x | 1.62x | 10.38x | 2.27% | 20.2B | |
| 20.15x | 1.29x | 8.38x | 1.3% | 19.39B | |
| 15.58x | 1.5x | 8.61x | 3.41% | 19B | |
| Average | 24.07x | 2.98x | 13.83x | 2.7% | 72.54B | |
| Weighted average by Cap. | 22.82x | 3.61x | 14.71x | 2.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NOVATEOR Stock
- Valuation Novateor Research Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
